Dopamine Transport by the Serotonin Transporter: a Mechanistically Distinct Mode of Substrate Translocation
Overview
Authors
Affiliations
The serotonin transporter (SERT) is the principal mechanism for terminating serotonin (5-HT) signals in the nervous system and is a site of action for a variety of psychoactive drugs including antidepressants, amphetamines, and cocaine. Here we show that human SERTs (hSERTs) and rat SERTs are capable of robust dopamine (DA) uptake through a process that differs mechanistically from 5-HT transport in several unanticipated ways. DA transport by hSERT has a higher maximum velocity than 5-HT transport, requires significantly higher Na(+) and Cl(-) concentrations to sustain transport, is inhibited noncompetitively by 5-HT, and is more sensitive to SERT inhibitors, including selective serotonin reuptake inhibitors. We use a thiol-reactive methane thiosulfonate (MTS) reagent to modify a conformationally sensitive cysteine residue to demonstrate that hSERT spends more time in an outward facing conformation when transporting DA than when transporting 5-HT. Cotransfection of an inactive or an MTS-sensitive SERT with wild-type SERT subunits reveals an absence of cooperative interactions between subunits during DA but not 5-HT transport. To establish the physiological relevance of this mechanism for DA clearance, we show using in vivo high-speed chronoamperometry that SERT has the capacity to clear extracellularly applied DA in the hippocampal CA3 region of anesthetized rats. Together, these observations suggest the possibility that SERT serves as a DA transporter in vivo and highlight the idea that there can be distinct modes of transport of alternative physiological substrates by SERT.
Fluorescent non-canonical amino acid provides insight into the human serotonin transporter.
Nygaard A, Zachariassen L, Larsen K, Kristensen A, Loland C Nat Commun. 2024; 15(1):9267.
PMID: 39463388 PMC: 11514162. DOI: 10.1038/s41467-024-53584-9.
The nucleus accumbens in reward and aversion processing: insights and implications.
Xu Y, Lin Y, Yu M, Zhou K Front Behav Neurosci. 2024; 18:1420028.
PMID: 39184934 PMC: 11341389. DOI: 10.3389/fnbeh.2024.1420028.
Oligomerization of Monoamine Transporters.
Paul A, Shukla D Subcell Biochem. 2024; 104:119-137.
PMID: 38963486 DOI: 10.1007/978-3-031-58843-3_7.
Chen Y, Kuo T, Wang V, Cheng P, Yi-Kung Huang E, Ma K J Parkinsons Dis. 2024; 14(5):941-964.
PMID: 38905058 PMC: 11307072. DOI: 10.3233/JPD-240080.
Traktirov D, Nazarov I, Artemova V, Gainetdinov R, Pestereva N, Karpenko M Biomedicines. 2023; 11(11).
PMID: 38001881 PMC: 10669523. DOI: 10.3390/biomedicines11112881.